Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Haifa
Clinical trial register · Israel

Clinical Trials in Haifa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Jerusalem 37 Haifa 30 Petah Tikva 29 Ramat Gan 29 Beersheba 21
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC94 AbbVie52 Janssen Research & Development, LLC52 AstraZeneca49 Eli Lilly and Company30 Clear sponsor filter
Site location
Jerusalem37 Haifa30 Petah Tikva29 Ramat Gan29 Beersheba21
All 23 locations
Target enrolment
to

Trials with a site in Haifa

30 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
Eli Lilly and Company
Phase 3
150
Beer Jacob, Beersheba, Haifa, Jerusalem, Petah Tikva
2026-09-25
Recruiting
Eli Lilly and Company
Phase 2
60
Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
2026-05-04
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Ashdod, Ashkelon, Haifa, Jerusalem, Kfar Saba, Tsrifin
2026-03-26
Recruiting
Eli Lilly and Company
Phase 3
900
Afula, Atlit, Beersheba, Hadera, Haifa, Holon, Jerusalem, Kfar Saba
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
300
Beer Yaacov, Beersheba, Haifa, Herzliya, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
150
Beer Yaacov, Beersheba, Haifa, Herzliya, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
7,140
Ashdod, Ashkelon, Beersheba, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
1,205
Haifa, Jerusalem, Kfar Saba, Petah Tikva
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
4,500
Ashkelon, Beersheba, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2025-10-15
Recruiting
Eli Lilly and Company
Phase 3
350
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
2025-06-26
Active, closed
Eli Lilly and Company
Phase 3
905
Beer Yaacov, Beersheba, Haifa, Herzliya, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2025-04-25
Recruiting
Eli Lilly and Company
Phase 3
700
Haifa, Jerusalem, Kfar Saba, Ramat Gan
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
125
Beer Yaacov, Haifa, Jerusalem, Petah Tikva, Ramat Gan
2024-11-18
Recruiting
Eli Lilly and Company
Phase 3
300
Afula, Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2024-06-03
Active, closed
Eli Lilly and Company
Phase 3
10,000
Ashkelon, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan, Rehovot
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Afula, Beersheba, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
160
Beer Yaacov, Petah Tikva, Ramat Gan, Jerusalem, Afula, Haifa, Beersheba
2023-10-16
Active, closed
Eli Lilly and Company
Phase 3
15,374
Ashkelon, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
2022-10-04
Active, closed
Eli Lilly and Company
Phase 4
780
Holon, Petah Tikva, Ramat Gan, Rehovot, Jerusalem, Haifa, Sakhnin, Atlit
2022-08-01
Active, closed
Eli Lilly and Company
Phase 3
925
Kfar Saba, Petah Tikva, Ramat Gan, Tsrifin, Jerusalem, Haifa, Tel Aviv
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
152
Ramat Gan, Jerusalem, Haifa
2021-12-20
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Beersheba, Haifa, Jerusalem, Petah Tikva, Tsrifin
2021-05-26
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
Haifa
2020-11-19
Active, closed
Eli Lilly and Company
Phase 3
261
Beersheba, Jerusalem, Ramat Gan, Haifa
2020-02-17
Recruiting
Eli Lilly and Company
Phase 3
190
Haifa, Kfar Saba, Petah Tikva, Ramat Gan
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
5,637
Kfar Saba, Petah Tikva, Ramat Gan, Rehovot, Tsrifin, Jerusalem, Beersheba, Haifa
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
493
Petah Tikva, Ramat Gan, Rehovot, Jerusalem, Beersheba, Kfar Saba, Tel Aviv, Haifa
2014-11-06
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-israel/city/haifa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Haifa that also match the filters currently applied.

How many clinical trials are recruiting in Haifa?

17 of the 30 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Haifa), 30 studies
PhaseStudiesRecruitingShare
Phase 3251483.3%
Phase 23310%
Phase 1103.3%
Phase 4103.3%

Most active sponsors

Lead sponsors with the most studies (Haifa)
Lead sponsorStudiesRecruiting
Eli Lilly and Company3017
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.